# Biotech
Before Covid, We Are Already Doing Gain-of-Function Research. But Why?
Examples of potential pandemic pathogens (PPP) include the influenza virus, SARS, and MERS — pathogens that may evolve into a pandemic. Gain-of-function (GOF) experiments, therefore, aim to emulate the evolution of a pathogen — such as in gaining virulence, infectivity, or transmissibility — to study what potential outbreaks or pandemics might look like. But is it wise to perform such GOF research?
Reliable Custom Antibody Production
The biological and chemical processes of life consist of various crucial factors. There are building blocks or compounds that, as their name suggests, formulate the backbone of life on a cellular level, and when they combine with other elements, they play a crucial functionary role.
Facebook Founder Mark Zuckerberg and Wife to Invest $250 Million in Biomedical Research in Chicago
Chicago's Biomedical Research Landscape Set for Transformation with Zuckerberg Investment. The Chan Zuckerberg Initiative (CZI) announced the launch of a new biomedical research hub in Chicago, Illinois, that "will bring together leading scientific and technology institutions with the goal of solving grand scientific challenges on a 10- to 15-year time horizon."
Related Contributors
Biotech company raises $250 million; aims to bring back some extinct animals but some questions remain
Craving some dodo eggs? Not that fast. You'll have to continue shelling out more for your breakfast omelet. Egg prices have shot up by about 60% since December last year. Not to worry, Colossal Biosciences, a genetic engineering company has gotten closer to its dream of resurrecting the dodo, an infamously-unlucky bird that went extinct in Mauritius by 1681.
New compound destroys breast cancer
ERX-41 has been shown to kill all types of breast cancer cells and other forms of human cancerous tumors.Photo byAngiola Harry on UnsplashonUnsplash. A newly created compound, ERX-41, has been found to kill a wide range of hard-to-treat types of cancers.
The Biggest Reason Why Lab-Grown Meat Won't Match Real Steaks
Why can’t we 3D print a steak, like in the Jetsons?Photo by Rob Wingate on Unsplash. It’s a dream of science fiction that harkens back to the Jetsons, or The Fifth Element; some sort of machine that produces food from nothing. And not just food — meat, tasty and delicious steaks, chicken, and pork, all without ever needing to go through the nasty business of raising and butchering an animal.
InnoCan Pharma Reports Impressive Preclinical Trial Results as it Eyes Expansion into $52b Veterinary Services Industry
InnoCan Pharma Corporation, an Israeli pharmaceutical technology company and pioneer in CBD-Pharma delivery systems, reported positive results in a preclinical trial on epileptic seizures in dogs using LPT. The company is conducting this research in collaboration with Yissum, the commercial arm of The Hebrew University of Jerusalem.
MeaTech 3D is developing cultured meat to take customized food to the next level
An investment in the future of food ― meet the company that is going to enable the production of real delicious, nutritious meat that’s slaughter-free. MeaTech 3D (Nasdaq: MITC) is a global deep-tech food company developing the advanced biotechnology and engineering capabilities to produce delicious, nutritious real meat made from cells rather than slaughtered animals. The company has been advancing its bio-printing technology in order to circumvent unsustainable challenges faced by conventional animal husbandry, such as the industry’s enormous carbon footprint, water and land usage, and animal welfare issues. Importantly, MeaTech has just made an announcement confirming a significant upgrade to its technology that should help the company continue accelerating its progress toward commercialization.
Alameda biotech building bought for $150 million
(Arne Dedert - Pool / Getty Images) (ALAMEDA, Calif.) A large office building in Alameda currently leased by a rapidly expanding biotech company was recently purchased by a veteran commercial real estate investment firm.